CY1113739T1 - Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ - Google Patents

Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ

Info

Publication number
CY1113739T1
CY1113739T1 CY20121101207T CY121101207T CY1113739T1 CY 1113739 T1 CY1113739 T1 CY 1113739T1 CY 20121101207 T CY20121101207 T CY 20121101207T CY 121101207 T CY121101207 T CY 121101207T CY 1113739 T1 CY1113739 T1 CY 1113739T1
Authority
CY
Cyprus
Prior art keywords
increased
tolerance
lactic acid
acid
acid bacteria
Prior art date
Application number
CY20121101207T
Other languages
English (en)
Inventor
Eamonn Connolly
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of CY1113739T1 publication Critical patent/CY1113739T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Η εφεύρεση παρέχει ορισμένα διορθωμένου πλασμιδίου στελέχη βακτηριδίων γαλακτικού οξέος τροποποιημένα για την ικανότητα αυτών καλύτερης ανοχής σε οξύ, μέθοδο τροποποίησης τέτοιων στελεχών και προϊόντα που περιέχουν τέτοια στελέχη.
CY20121101207T 2006-06-05 2012-12-10 Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ CY1113739T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/446,648 US8603460B2 (en) 2006-06-05 2006-06-05 Method of making a Lactobacillus reuteri with increased acid tolerance
EP07748543A EP2040723B1 (en) 2006-06-05 2007-05-30 Lactic acid bacterium with increased acid tolerance

Publications (1)

Publication Number Publication Date
CY1113739T1 true CY1113739T1 (el) 2016-06-22

Family

ID=38790469

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121101207T CY1113739T1 (el) 2006-06-05 2012-12-10 Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ

Country Status (13)

Country Link
US (1) US8603460B2 (el)
EP (2) EP2040723B1 (el)
JP (1) JP2009539372A (el)
KR (1) KR20090014264A (el)
CN (1) CN101432006B (el)
CY (1) CY1113739T1 (el)
DK (1) DK2040723T3 (el)
ES (1) ES2398590T3 (el)
HK (1) HK1132659A1 (el)
PL (1) PL2040723T3 (el)
PT (1) PT2040723E (el)
SI (1) SI2040723T1 (el)
WO (1) WO2007142597A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
CN101649353B (zh) * 2009-09-21 2013-04-24 内蒙古农业大学 益生菌乳制品中罗伊氏乳杆菌的快速定性、定量测定方法
CN101993152B (zh) * 2010-09-21 2012-06-20 浙江大学 一种增强油脂降解菌降解能力的激活剂及其用途和使用方法
EP3040412A4 (en) * 2013-08-23 2017-04-05 Consejo Superior De Investigaciones Científicas (CSIC) Probiotic strain of lactobacillus reuteri exhibiting anti-helicobacter activity, a probiotic or biotherapeutic product comprising said strain, and the use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508738A (en) * 1982-03-17 1985-04-02 Microlife Technics, Inc. Non-sucrose fermenting Pedioccus pentosaceus
US4518696A (en) * 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5080897A (en) * 1987-05-08 1992-01-14 Ecogen Inc. Novel bacillus thuringiensis strains, and related insecticidal compositions
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
CA2213434C (en) * 1995-12-21 2008-12-09 Abbott Laboratories Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) * 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR19990024297A (ko) * 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US7045338B2 (en) * 2002-03-08 2006-05-16 E. I. Du Pont De Nemours And Company Temperature sensitive mutant derivatives of the broad host range plasmid pBHR1
GB0205647D0 (en) 2002-03-11 2002-04-24 Danisco Cultor Niebull Gmbh Method of improving food fermentation procedures
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
EP2040723A4 (en) 2010-06-16
PL2040723T3 (pl) 2013-03-29
JP2009539372A (ja) 2009-11-19
EP2040723A1 (en) 2009-04-01
DK2040723T3 (da) 2013-03-25
US20070280914A1 (en) 2007-12-06
EP2548945A2 (en) 2013-01-23
EP2548945A3 (en) 2013-04-24
WO2007142597A1 (en) 2007-12-13
SI2040723T1 (sl) 2013-03-29
EP2040723B1 (en) 2012-11-28
CN101432006A (zh) 2009-05-13
ES2398590T3 (es) 2013-03-20
CN101432006B (zh) 2012-08-22
US8603460B2 (en) 2013-12-10
KR20090014264A (ko) 2009-02-09
HK1132659A1 (en) 2010-03-05
PT2040723E (pt) 2013-01-29

Similar Documents

Publication Publication Date Title
CY1122285T1 (el) Ψημενα προϊοντα
CY1118875T1 (el) Αντιδοτα αντιπηκτικων
CY1118349T1 (el) Παραγοντες συνδεσης me cd19 και χρησεις αυτων
MY169996A (en) Biocatalytic oxidation process with alkl gene product
CL2009000879A1 (es) Metodo para fabricar un producto en un biorreactor que comprende cultivar microorganismos que son adaptados o mutagenizados para que exhiban por lo menos un 150% de tolerancia al producto; sistema para fabricar un producto; biorreactor.
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
EA201190008A1 (ru) Термофильные микроорганизмы не способные к спорообразованию для продукции этанола
NO20090879L (no) Titandioksidinneholdende kompositt
BRPI0918641A8 (pt) Produtos infantis pró-bióticos.
RS54919B1 (sr) Bakterija za upotrebu kao probiotik za nutritivne i medicinske primene
CY1112075T1 (el) Θεραπεια πιρφενιδονης κι επαγωγεις κυτοχρωματος ρ450
DE602007004086D1 (de) Acrylierte hyaluronsäure
MX2012008738A (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato.
CY1118710T1 (el) Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης
EA200870290A1 (ru) Молочно-кислые бактерии, обеспечивающие улучшенную текстуру ферментированных молочных продуктов
BRPI1014056A2 (pt) micro-organismos de corynebacterium com maior produtividade de ácido 5'-inosínico e método para produzir ácidos nucleicos com eles.
CY1113739T1 (el) Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ
RU2011135537A (ru) Штамм enterococcus hirae, используемый при производстве кисломолочных продуктов
BR112017011850A2 (pt) métodos e reagentes para detectar neisseria gonorrhoeae e seus determinantes de resistência antimicrobiana
IN2012DN01604A (el)
FR2905560B1 (fr) Produits laitiers.
CY1113641T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει aleglitazar
GR1007010B (el) Ινσουλινοειδη πεπτιδια
ATE511810T1 (de) Abziehpackung zur sterilisation
BRPI0823125A2 (pt) Artigo de acondicionamento, método, e, composicao sequestrante de oxigênio.